Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After Brexit

Set Alert for Brexit Watch

Latest From Brexit

EU Notified Bodies Advise Manufacturers To Think Hard About Regulatory Strategy Timings

Waiting until the grace period expires before making a product application under the EU MDR or IVDR is a gambit that could easily misfire, TEAM-NB warns.

EU Compliance

Complexity And Confusion At The Border As UK Medtech Faces New EU Trading Arrangements

The end of the UK’s Brexit transition was the beginning of its new relationship as a “third country” with the EU.

Trade Policy

UK Government Promise For 2021: No Halting The Advance Of Healthtech Innovation Adoption

There can be no such thing as a COVID dividend, but the renewed digital push and momentum for health system change perhaps come closest.

United Kingdom Policy

UK Medtechs Determined To Exploit Digital Health Opportunity Born From The Pandemic

COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.

United Kingdom Policy

Top 20 EU Regulatory Stories Of 2020: Nightmare Year With Brexit, MDR Implementation … And COVID-19

Not only might each day feel like Groundhog Day now – with COVID-19 limiting everyone’s activities. But early 2021 puts the EU medtech sector in a similar place to early 2020. So what has changed?

Europe EU

UK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays

Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.

United Kingdom Brexit

Raft Of MHRA Guidance And Govt Trade Advice Greet UK Medtechs At Start Of Year

Preparations for Brexit and the UK’s new medtech regulatory system kept the MHRA busy over the holiday period and into the new year.

United Kingdom Brexit

EU Regulatory Roundup, December 2020: UK Break With EU Tops News Amidst MDR Preparations Latest

Four out of 10 of Medtech Insight's top EU stories were dominated by news related to the implications for medtech of the UK’s final break from the EU on 31 December. But no one should ignore the pressure that implementation of the new EU medtech regulations is causing.

Europe United Kingdom

UK/EU Free-Trade Deal Sees Hopes Of Mutual Recognition Of Medtech Regs Fade

“No deal” is finally off the table for the UK trade in goods, after an 11th hour deal was agreed with the EU. But for UK medtech trade and regulation, the decision effectively means a “hard Brexit.”

Brexit United Kingdom
See All
UsernamePublicRestriction

Register